2025-11791RuleWallet

FDA Gives X-Ray-Blocking Cream Its Own Official Device Classification

Published Date: 6/26/2025

Rule

Summary

The FDA is officially classifying the cream used to block X-rays as a Class II device with special safety rules. This change makes it easier and safer for patients to get this innovative cream by lowering regulatory hurdles. The new classification is effective June 26, 2025, and helps companies bring these creams to market faster without extra costs.

Analyzed Economic Effects

4 provisions identified: 3 benefits, 0 costs, 1 mixed.

Cream classified Class II; access improved

You may get faster access to this X-ray attenuation cream because the FDA officially classified it as Class II with special controls, effective June 26, 2025 (the classification was applicable May 9, 2013). The FDA says this classification reduces regulatory burdens and will enhance patients' access to this innovative device.

Device uses 510(k) pathway (not PMA)

The cream for X-ray attenuation is subject to premarket notification under section 510(k) rather than premarket approval, and the De Novo classification lets this device serve as a predicate for future devices. That means manufacturers can use the less burdensome 510(k) process to bring similar products to market.

Mandatory testing and labeling requirements

Manufacturers must perform specific safety and performance testing (including biocompatibility, sterilization/expiration testing, glove compatibility, attenuation performance, and application testing) and include labeling such as a sterility statement and boxed warning. Labeling must also give attenuation results at 60, 80, 100, and 120 kVp, identify compatible glove types, and include validated instructions for how and how often to apply or reapply the cream.

Use limits: up to 130 kVp; not for primary beam

The cream is intended as a sterile radiation shield for hands during procedures with diagnostic imaging exposure up to 130 kVp; it should be applied to the hand before donning gloves or on a glove followed by a second glove. The device must not be used in or next to the primary X-ray beam and should not replace a Radiographic Procedure Glove for procedures requiring direct exposure.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Rule Effective
6/26/2025
6/26/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register